1. Home
  2. GNLN vs NXL Comparison

GNLN vs NXL Comparison

Compare GNLN & NXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLN
  • NXL
  • Stock Information
  • Founded
  • GNLN 2005
  • NXL 2010
  • Country
  • GNLN United States
  • NXL United States
  • Employees
  • GNLN N/A
  • NXL N/A
  • Industry
  • GNLN Durable Goods
  • NXL Medical Specialities
  • Sector
  • GNLN Consumer Discretionary
  • NXL Health Care
  • Exchange
  • GNLN Nasdaq
  • NXL Nasdaq
  • Market Cap
  • GNLN 12.9M
  • NXL 14.0M
  • IPO Year
  • GNLN 2019
  • NXL 2022
  • Fundamental
  • Price
  • GNLN $3.75
  • NXL $0.79
  • Analyst Decision
  • GNLN
  • NXL Strong Buy
  • Analyst Count
  • GNLN 0
  • NXL 1
  • Target Price
  • GNLN N/A
  • NXL $5.00
  • AVG Volume (30 Days)
  • GNLN 89.4K
  • NXL 2.9M
  • Earning Date
  • GNLN 11-14-2025
  • NXL 11-07-2025
  • Dividend Yield
  • GNLN N/A
  • NXL N/A
  • EPS Growth
  • GNLN N/A
  • NXL N/A
  • EPS
  • GNLN N/A
  • NXL N/A
  • Revenue
  • GNLN $7,954,000.00
  • NXL $174,813.00
  • Revenue This Year
  • GNLN $1,541.21
  • NXL $38.28
  • Revenue Next Year
  • GNLN N/A
  • NXL $185.71
  • P/E Ratio
  • GNLN N/A
  • NXL N/A
  • Revenue Growth
  • GNLN N/A
  • NXL 16.42
  • 52 Week Low
  • GNLN $2.84
  • NXL $0.59
  • 52 Week High
  • GNLN $5,130.00
  • NXL $4.49
  • Technical
  • Relative Strength Index (RSI)
  • GNLN 52.27
  • NXL 41.85
  • Support Level
  • GNLN $3.35
  • NXL $0.79
  • Resistance Level
  • GNLN $3.90
  • NXL $0.85
  • Average True Range (ATR)
  • GNLN 0.25
  • NXL 0.07
  • MACD
  • GNLN 0.10
  • NXL 0.00
  • Stochastic Oscillator
  • GNLN 80.00
  • NXL 4.52

About GNLN Greenlane Holdings Inc.

Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Share on Social Networks: